IRD Opus Genetics, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 6, 2026
$4,58
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$1,7052 haftanın en düşüğü
$7,0752 haftanın en yükseği
Piyasa Değeri (MRQ)
$379M
P/E (TTM)
-3.4
Hisse Başına Kâr (TTM)
$-1.33
Gelir (TTM)
$10M
rozetleriniz
52 Haftlık Aralık
$2–$7
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$13
P/E
-3.4
ROE
-4796.5%
Net Kâr Marjı
-1091.8%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
IRD Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$4.58
Piyasa Değeri (MRQ)
$379M
P/E (TTM)
-3.4
Hisse Başına Kâr (TTM)
$-1.33
Gelir (TTM)
$10M
ROE (TTM)
-4796.5%
D/E Borç/Özsermaye
0.1
52 Haftlık Aralık
$2–$7
IRD Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 06 Kasım 2020 | 1-for-4 | Ters |
| 12 Nisan 2019 | 1-for-12 | Ters |
| 05 Mayıs 2017 | 1-for-10 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$14M2020-12-31 → 2025-12-31
Hisse Başına Kâr$-0.802020-12-31 → 2025-12-31
Serbest Nakit Akışı·2020-12-31 → 2020-12-31
Net kar marjı-1091.8%2021-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | IRD | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -3.45Y ort. ≈-1.3 | ≈-1.3 | · | · | |
| F/S (TTM) | 38.45Y ort. ≈27.7 | ≈27.7 | 6.5 | Aşırı değerli | |
| F/D (MRQ) | -29.15Y ort. ≈4.2 | ≈4.2 | · | · | |
| EV / EBITDA | -7.3 | · | · | · | |
| Price / Cash Flow (Fiyat / Nakit Akışı) | -9.35Y ort. ≈-13.8 | ≈-13.8 | · | · | |
| EV / Revenue (EV / Gelir) | 19.9 | · | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 21.35Y ort. ≈4.2 | ≈4.2 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | IRD | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | -513.5%5Y ort. ≈-940.2% | ≈-940.2% | -683.0% | Zayıf | |
| EBITDA Margin (FAVÖK Marjı) | -271.9%5Y ort. ≈-940.2% | ≈-940.2% | -683.0% | Zayıf | |
| Vergi Öncesi Kar Marjı (TTM) | -1091.8%5Y ort. ≈-2100.9% | ≈-2100.9% | -404.3% | Zayıf | |
| Net Kâr Marjı (TTM) | -1091.8%5Y ort. ≈-2101.1% | ≈-2101.1% | -673.2% | Zayıf | |
| ROA (TTM) | -163.5%5Y ort. ≈-94.3% | ≈-94.3% | -30.6% | Zayıf | |
| ROE (TTM) | -4796.5%5Y ort. ≈-161.2% | ≈-161.2% | -80.3% | Zayıf | |
| ROIC | -234.3%5Y ort. ≈-247.9% | ≈-247.9% | -46.7% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | IRD | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Debt / Equity (Borç / Öz Sermaye) | 0.15Y ort. ≈0.0 | ≈0.0 | 0.1 | Düşük borç | |
| Cari Oran (MRQ) | 12.25Y ort. ≈9.5 | ≈9.5 | 5.9 | Güçlü likidite | |
| Quick Ratio (Cari Oran) | 6.15Y ort. ≈7.6 | ≈7.6 | 5.8 | Güçlü likidite | |
| Long-Term Debt / Equity (Uzun Vadeli Borç / Özkaynak) | 0.1 | · | 0.1 | Düşük borç |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | IRD | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 29.1%5Y ort. ≈1650.1% | ≈1650.1% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -29.1% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | IRD | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.35Y ort. ≈0.4 | ≈0.4 | 0.3 | Aynı seviyede | |
| Receivables Turnover (Alacak Devir Hızı) | 5.15Y ort. ≈22.1 | ≈22.1 | 9.7 | Zayıf | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$525.8K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-93.7%
Sonraki Rapor
Kas 10, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 11, 2026 | $-0.08 | $-0.16 | 49.5% |
| 31 Mart 2026 | May 13, 2026 | $-0.75 | $-0.14 | -421.2% |
| 31 Aralık 2025 | $-0.29 | $-0.12 | -146.8% | |
| 30 Eylül 2025 | $-0.25 | $-0.13 | -90.4% | |
| 30 Haziran 2025 | $-0.12 | $-0.21 | 42.1% | |
| 31 Mart 2025 | $-0.24 | $-0.25 | 5.0% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14M | $11M | $19M | $40M | $589.0K | $0 | · | · | · | · | · | · | |
| R&D Expense | · | · | · | · | · | · | $5M | $13M | $11M | $10M | $12M | $7M | |
| SG&A Expense | $22M | $18M | $12M | $7M | $8M | $3M | $2M | $7M | $7M | $6M | $6M | $6M | |
| Operating Expenses | $53M | $73M | $30M | $22M | $23M | $20M | $4M | $21M | $17M | $16M | $18M | $13M | |
| Operating Income | $-39M | $-62M | $-11M | $18M | $-23M | $-20M | $-4M | $-21M | $-17M | $-16M | $-18M | $-13M | |
| Interest Expense | · | · | $0 | $9.0K | $2.0K | $7M | $1M | · | · | · | · | · | |
| Interest Income | · | · | · | · | · | · | $313.7K | $254.3K | $207.0K | $118.6K | $103.3K | $133.9K | |
| Other Non-op | $2M | $4M | $2M | $-14.0K | $-157.0K | $9.0K | $-68.0K | $6M | $-8M | $7M | $4M | $-5M | |
| Pretax Income | $-50M | $-58M | $-10M | $18M | $-57M | $-25M | $-6M | · | · | · | · | · | |
| Income Tax | $0 | $0 | $12.0K | $315.0K | $0 | $0 | $0 | · | · | · | · | · | |
| Net Income | $-50M | $-58M | $-10M | $18M | $-57M | $-25M | $-6M | $-14M | $-25M | $-9M | $-14M | $-19M | |
| EPS (Basic) | $-0.80 | $-2.15 | $-0.46 | $0.90 | $-3.82 | $-5.28 | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.80 | $-2.15 | $-0.46 | $0.87 | $-3.82 | $-5.28 | · | · | · | · | · | · | |
| Shares (Basic) | 62,221,901 | 26,715,526 | 21,589,821 | 19,931,080 | 14,852,745 | 4,661,110 | · | · | · | · | · | · | |
| Shares (Diluted) | 62,221,901 | 26,715,526 | 21,589,821 | 20,597,212 | 14,852,745 | 4,661,110 | · | · | · | · | · | · | |
| EBITDA | $-39M | $-62M | $-11M | $18M | $-23M | $-20M | · | $-21M | $-17M | $-16M | $-18M | $-13M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $45M | $30M | $51M | $43M | $25M | · | $12M | $9M | $9M | $12M | $10M | $10M | |
| Short-term Investments | $0 | $2.0K | $15.0K | $49.0K | $219.0K | $0 | $3M | $6M | $18M | $9M | $13M | $23M | |
| Receivables | $2M | $4M | $926.0K | $1M | $0 | $0 | · | · | · | · | · | · | |
| Prepaid Expense | $2M | $515.0K | $1M | $1M | $1M | $1M | $149.0K | $1M | $1M | $608.5K | $1M | $731.0K | |
| Other Current Assets | · | · | $102.0K | $80.0K | $71.0K | $26.0K | $5.0K | $555.4K | $510.6K | $429.0K | $720.6K | $361.2K | |
| Current Assets | $50M | $37M | $54M | $49M | $26M | $18M | $2M | $16M | $28M | $21M | $25M | $33M | |
| PP&E (Net) | $199.0K | $252.0K | $0 | $6.0K | $10.0K | $14.0K | $22.0K | $112.5K | $121.5K | $88.7K | $112.9K | $78.1K | |
| PP&E (Gross) | · | · | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $821.6K | $833.3K | $758.1K | $749.5K | $687.2K | |
| Accum. Depreciation | · | · | $25.0K | $19.0K | $15.0K | $11.0K | $3.0K | $709.1K | $711.8K | $669.5K | $636.6K | $609.1K | |
| Total Assets | $50M | $37M | $54M | $49M | $26M | $18M | $2M | $16M | $28M | $21M | $25M | $34M | |
| Accounts Payable | $3M | $3M | $2M | $1M | $2M | $1M | $342.0K | $3M | $3M | $2M | $3M | $2M | |
| Accrued Liabilities | $4M | $8M | $2M | $2M | $2M | $2M | $621.0K | · | · | · | · | · | |
| Short-term Debt | · | · | · | $0 | $538.0K | $0 | · | · | · | · | · | · | |
| Current Liabilities | $8M | $11M | $4M | $3M | $4M | $3M | $9M | $3M | · | · | · | · | |
| Capital Leases | · | · | · | · | · | · | $63.6K | · | · | · | · | · | |
| Total Liabilities | $35M | $11M | $4M | $3M | $4M | $31M | $9M | $5M | $12M | $4M | $6M | $7M | |
| Total Debt | $1M | · | · | $0 | $538.0K | · | · | · | · | · | · | · | |
| Common Stock | $7.0K | $3.0K | $2.0K | $2.0K | $2.0K | $1.0K | $0 | $312 | $3.2K | $2.4K | $19.7K | $17.8K | |
| Paid-in Capital | $204M | $146M | $131M | $118M | $112M | $19M | $495.0K | · | · | · | · | · | |
| Retained Earnings | $-189M | $-139M | $-81M | $-71M | $-89M | $-33M | $-8M | $-155M | $-140M | $-115M | $-106M | $-91M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | · | $128.4K | |
| AOCI | · | · | · | · | · | · | $2.1K | $-17.8K | $-56.9K | $-6.1K | $-18.0K | $-33.6K | |
| Stockholders' Equity | $15M | $7M | $50M | $46M | $22M | $-13M | $-8M | $-2M | $17M | $17M | $19M | $27M | |
| Liabilities + Equity | $50M | $37M | $54M | $49M | $26M | $18M | $2M | $16M | $28M | $21M | $25M | $34M | |
| Shares Outstanding | 69,894,507 | 31,574,657 | 23,977,491 | 20,861,315 | 18,845,828 | 10,882,495 | 2,852,485 | 3,122,843 | 2,639,319 | 23,736,878 | 19,741,378 | 17,836,652 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | $41.0K | $48.2K | $42.4K | $32.9K | $27.5K | $28.3K | |
| Stock-based Comp | $3M | $3M | $4M | $2M | $2M | $2M | $308.0K | $1M | $1M | $1M | $1M | $608.8K | |
| Operating Cash Flow | $-35M | $-26M | $-1M | $14M | $-19M | $-7M | $-4M | $-19M | $-15M | $-13M | $-17M | $-11M | |
| CapEx | · | · | · | · | · | $0 | $25.0K | · | · | · | · | · | |
| Investing Cash Flow | $0 | $1M | $0 | $0 | $-100.0K | $539.0K | $-25.0K | $12M | $-9M | · | · | · | |
| Stock Issued | $6M | $4M | $9M | $4M | $28M | $0 | $8M | $7M | $17M | · | $1M | · | |
| Net Stock Activity | $6M | $4M | $9M | $4M | $28M | · | · | $7M | · | · | · | · | |
| Financing Cash Flow | $50M | $4M | $9M | $4M | $28M | $21M | $5M | $7M | $22M | · | · | · | |
| Net Change in Cash | · | · | · | · | · | · | · | $-154.9K | $-3M | $1M | $373.2K | $-9M | |
| Taxes Paid | $0 | $0 | $344.0K | $0 | $0 | $0 | $0 | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | $-7M | · | · | · | · | · | · | |
| Levered FCF | · | · | · | · | · | $-14M | · | · | · | · | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -271.9% | -564.7% | -55.5% | 45.7% | -3854.8% | · | · | · | · | · | · | · | |
| Net Margin | -349.3% | -523.4% | -52.4% | 44.9% | -9625.3% | · | · | · | · | · | · | · | |
| Pretax Margin | -349.3% | -523.4% | -52.4% | 45.7% | -9625.3% | · | · | · | · | · | · | · | |
| EBITDA Margin | -271.9% | -564.7% | -55.5% | 45.7% | -3854.8% | · | · | · | · | · | · | · | |
| ROA | -113.9% | -126.7% | -19.4% | 47.7% | -259.1% | -253.0% | · | -64.8% | -102.6% | -40.6% | -49.3% | -69.8% | |
| ROE | -302.2% | -280.5% | -19.9% | 61.6% | -265.0% | 215.2% | · | -169.3% | -149.6% | -51.9% | -63.4% | -94.5% | |
| ROIC | -234.3% | -923.2% | -21.2% | 38.7% | -99.8% | 148.3% | · | · | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.4 | 3.2 | 13.3 | 17.8 | 6.8 | 5.5 | · | · | · | · | · | · | |
| Quick Ratio | 6.1 | 3.0 | 12.7 | 16.0 | 0.1 | · | · | · | · | · | · | · | |
| Debt / Equity | 0.1 | · | · | 0.0 | 0.0 | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.1 | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | 2025.1 | -11352.5 | -2.9 | · | · | · | · | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | 0.4 | 1.1 | 0.0 | · | · | · | · | · | · | · | |
| Receivables Turnover | 5.1 | 4.9 | 17.1 | 61.4 | · | · | · | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.22 | $0.21 | $2.08 | $2.22 | $1.18 | $-1.24 | · | $0.28 | $0.53 | $0.07 | $0.10 | $0.15 | |
| Revenue / Share | $0.23 | $0.41 | $0.88 | $1.93 | $0.04 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.57 | $-0.96 | $-0.05 | $0.69 | $-1.30 | · | · | · | · | · | · | · | |
| Cash / Share | $0.65 | $0.96 | $2.11 | $2.04 | · | · | · | $0.23 | $0.28 | $0.05 | $0.05 | $0.06 | |
| EPS (TTM) | $-0.80 | $-2.15 | $-0.46 | $0.87 | $-3.82 | $-5.28 | $-0.25 | $-0.25 | $-1.04 | · | · | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 29.1% | -42.3% | -52.2% | 6665.7% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -29.1% | 165.2% | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $14M | $11M | $19M | $40M | $589.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-50M | $-58M | $-10M | $18M | $-57M | $-25M | $-6M | $-14M | $-25M | $-9M | $-14M | $-19M | |
| Market Cap | $140M | $38M | $72M | $74M | $70M | $71M | · | $1.68B | $3.08B | $15.95B | $34.11B | $59.89B | |
| Enterprise Value | $97M | · | · | $31M | · | · | · | · | · | · | · | · | |
| P/E | -2.5 | -0.6 | -6.5 | 4.1 | -1.0 | -1.2 | -30.6 | -178.6 | -93.2 | · | · | · | |
| P/S | 9.9 | 3.4 | 3.8 | 1.8 | 119.3 | · | · | · | · | · | · | · | |
| P/B | 9.2 | 5.6 | 1.4 | 1.6 | 3.2 | -5.2 | · | 158.6 | 183.4 | 935.1 | 1816.9 | 2253.3 | |
| P / Tangible Book | 9.2 | 5.6 | 1.4 | 1.6 | 3.2 | · | · | · | · | · | · | · | |
| P / Cash Flow | -4.0 | -1.5 | -64.9 | 5.1 | -3.6 | -10.4 | · | -88.9 | -199.5 | -1205.9 | -1966.0 | -5424.5 | |
| P / FCF | · | · | · | · | · | -10.4 | · | · | · | · | · | · | |
| EV / EBITDA | -2.5 | · | · | 1.7 | · | · | · | · | · | · | · | · | |
| EV / Revenue | 6.8 | · | · | 0.8 | · | · | · | · | · | · | · | · | |
| Earnings Yield | -39.8% | -180.7% | -15.3% | 24.6% | -102.4% | -81.4% | -3.3% | -0.56% | -1.1% | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $755.0K | $2M | $4M | $3M | $3M | $4M | $4M | $4M | $1M | $2M | $2M | $12M | $4M | $2M | $40M | $0 | |
| SG&A Expense | $6M | $6M | $5M | $5M | $6M | $6M | $7M | $3M | $3M | $5M | $3M | $2M | $4M | $2M | $2M | $2M | |
| Operating Expenses | $17M | $17M | $15M | $11M | $12M | $14M | $42M | $12M | $9M | $9M | $7M | $6M | $9M | $8M | $6M | $5M | |
| Operating Income | $-16M | $-14M | $-11M | $-8M | $-9M | $-10M | $-38M | $-8M | $-8M | $-8M | $-5M | $6M | $-5M | $-6M | $34M | $-5M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Other Non-op | $2M | $844.0K | $703.0K | $450.0K | $534.0K | $302.0K | $3M | $483.0K | $563.0K | $602.0K | $613.0K | $456.0K | $428.0K | $340.0K | $46.0K | $7.0K | |
| Pretax Income | $-8M | $-66M | $-17M | $-17M | $-7M | $-8M | $-35M | $-8M | $-8M | $-7M | $-5M | $6M | $-5M | $-6M | $34M | $-5M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-2.0K | $14.0K | $0 | $0 | $315.0K | $0 | |
| Net Income | $-8M | $-66M | $-17M | $-17M | $-7M | $-8M | $-35M | $-8M | $-8M | $-7M | $-5M | $6M | $-5M | $-6M | $34M | $-5M | |
| EPS (Basic) | $-0.08 | $-0.75 | $-0.19 | $-0.25 | $-0.12 | $-0.24 | $-1.27 | $-0.29 | $-0.30 | $-0.29 | $-0.20 | $0.26 | $-0.24 | $-0.28 | $1.72 | $-0.22 | |
| EPS (Diluted) | $-0.14 | $-0.75 | $-0.19 | $-0.25 | $-0.12 | $-0.24 | $-1.27 | $-0.29 | $-0.30 | $-0.29 | $-0.19 | $0.25 | $-0.24 | $-0.28 | $1.69 | $-0.22 | |
| Shares (Basic) | 95,483,280 | 86,891,352 | · | 70,636,887 | 63,376,392 | 33,884,920 | · | 26,145,080 | 25,827,265 | 24,520,475 | · | 21,446,648 | 20,959,807 | 20,939,607 | · | 20,498,229 | |
| Shares (Diluted) | 111,384,011 | 86,891,352 | · | 70,636,887 | 63,376,392 | 33,884,920 | · | 26,145,080 | 25,827,265 | 24,520,475 | · | 22,405,995 | 20,959,807 | 20,939,607 | · | 20,498,229 | |
| EBITDA | $-16M | $-14M | · | $-8M | $-9M | $-10M | · | $-8M | $-8M | $-8M | · | $6M | $-5M | $-6M | · | $-5M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $89M | $60M | $45M | $31M | $32M | $42M | $30M | $37M | $41M | $47M | $51M | $42M | $40M | $39M | $43M | $14M | |
| Short-term Investments | · | · | $0 | $0 | $0 | $1.0K | $2.0K | $3.0K | $5.0K | $5.0K | $15.0K | $11.0K | $22.0K | $22.0K | $49.0K | $101.0K | |
| Receivables | $1M | $2M | $2M | $3M | $3M | $3M | $4M | $2M | $1M | $2M | $926.0K | $10M | $135.0K | $3M | $1M | · | |
| Prepaid Expense | $2M | $4M | $2M | $815.0K | $1M | $1M | $515.0K | $429.0K | $1M | $2M | $1M | $484.0K | $732.0K | $1M | $1M | $605.0K | |
| Other Current Assets | · | · | · | · | · | · | · | $86.0K | $87.0K | $89.0K | · | $51.0K | $45.0K | $78.0K | $80.0K | $61.0K | |
| Current Assets | $93M | $67M | $50M | $36M | $38M | $48M | $37M | $40M | $45M | $52M | $54M | $54M | $43M | $45M | $49M | $15M | |
| PP&E (Net) | $172.0K | $186.0K | $199.0K | $212.0K | $226.0K | $239.0K | $252.0K | $0 | $0 | $0 | $0 | $3.0K | $4.0K | $5.0K | $6.0K | $7.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | $25.0K | $25.0K | $25.0K | · | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | |
| Accum. Depreciation | · | · | · | · | · | · | · | $25.0K | $25.0K | $25.0K | · | $22.0K | $21.0K | $20.0K | $19.0K | $18.0K | |
| Total Assets | $93M | $67M | $50M | $36M | $39M | $48M | $37M | $40M | $45M | $52M | $54M | $54M | $43M | $45M | $49M | $15M | |
| Accounts Payable | $2M | $4M | $3M | $2M | $1M | $2M | $3M | $844.0K | $634.0K | $2M | $2M | $2M | $2M | $2M | $1M | $1M | |
| Accrued Liabilities | · | · | $4M | · | · | · | $8M | $5M | $3M | $4M | $2M | $2M | $3M | $2M | $2M | $1M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Current Liabilities | $8M | $9M | $8M | $29M | $20M | $24M | $11M | $6M | $4M | $6M | $4M | $4M | $6M | $4M | $3M | $3M | |
| Total Liabilities | $106M | $88M | $35M | $30M | $21M | $24M | $11M | $6M | $4M | $6M | $4M | $4M | $6M | $4M | $3M | $3M | |
| Long-term Debt | $35M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | · | $1M | · | $1M | $1M | · | · | · | · | · | · | · | · | · | · | $0 | |
| Common Stock | $8.0K | $7.0K | $7.0K | $6.0K | $6.0K | $5.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | |
| Paid-in Capital | $249M | $208M | $204M | $178M | $172M | $152M | $146M | $138M | $137M | $135M | $131M | $127M | $120M | $119M | $118M | $117M | |
| Retained Earnings | $-262M | $-254M | $-189M | $-172M | $-155M | $-147M | $-139M | $-104M | $-96M | $-89M | $-81M | $-77M | $-82M | $-77M | $-71M | $-105M | |
| Stockholders' Equity | $-13M | $-46M | $15M | $6M | $17M | $5M | $7M | $34M | $41M | $46M | $50M | $50M | $38M | $41M | $46M | $12M | |
| Liabilities + Equity | $93M | $67M | $50M | $36M | $39M | $48M | $37M | $40M | $45M | $52M | $54M | $54M | $43M | $45M | $49M | $15M | |
| Shares Outstanding | 82,647,946 | 71,402,472 | 69,894,507 | 64,544,096 | 59,908,055 | 45,483,823 | 31,574,657 | 26,198,444 | 25,979,038 | 25,085,592 | 23,977,491 | 22,610,131 | 20,985,784 | 20,947,830 | 20,861,315 | 20,801,506 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $1M | $774.0K | $816.0K | $896.0K | $913.0K | $795.0K | $776.0K | $806.0K | $985.0K | $711.0K | $573.0K | $1M | $804.0K | $424.0K | $493.0K | |
| Operating Cash Flow | $-12M | $-13M | $-10M | $-6M | $-10M | $-9M | $-7M | $-5M | $-7M | $-6M | $5M | $-3M | $989.0K | $-4M | $29M | $-4M | |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 | $0 | $1M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Stock Issued | $0 | $2M | $179.0K | $5M | $0 | $409.0K | $0 | $456.0K | $2M | $2M | $4M | $5M | · | · | · | · | |
| Net Stock Activity | · | $2M | · | · | · | $409.0K | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $41M | $28M | $24M | $5M | $906.0K | $20M | $-83.0K | $353.0K | $2M | $2M | $4M | $5M | $0 | $0 | $-12.0K | $1M | |
| Net Change in Cash | $29M | $15M | · | · | $-9M | $11M | · | · | · | · | · | · | · | · | · | · | |
| Taxes Paid | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $26.0K | $318.0K | $0 | $0 | $0 | $0 |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2182.8% | -665.9% | · | -269.9% | -309.0% | -227.2% | · | -207.1% | -748.9% | -450.5% | · | 53.5% | -146.7% | -350.5% | · | · | |
| Net Margin | -1072.6% | -3038.2% | · | -566.9% | -257.5% | -187.5% | · | -194.6% | -698.3% | -415.3% | · | 46.6% | -135.0% | -331.1% | · | · | |
| Pretax Margin | -1072.6% | -3038.2% | · | -566.9% | -257.5% | -187.5% | · | -194.6% | -698.3% | -415.3% | · | 46.7% | -135.0% | -331.1% | · | · | |
| EBITDA Margin | -2182.8% | -665.9% | · | -269.9% | -309.0% | -227.2% | · | -207.1% | -748.9% | -450.5% | · | 53.5% | -146.7% | -350.5% | · | · | |
| ROA | -12.3% | -114.0% | · | -45.6% | -17.8% | -16.4% | · | -15.9% | -17.6% | -14.6% | · | 16.2% | -16.2% | -17.6% | · | -24.0% | |
| ROE | -360.9% | 321.5% | · | -86.7% | -25.5% | -32.0% | · | -17.8% | -19.8% | -16.3% | · | 17.9% | -19.0% | -19.8% | · | -27.9% | |
| ROIC | 126.9% | 32.2% | · | -118.1% | -48.2% | -195.7% | · | -23.4% | -20.5% | -16.7% | · | 12.7% | -14.3% | -14.9% | · | -38.2% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.2 | 7.1 | · | 1.2 | 1.9 | 2.0 | · | 6.6 | 10.7 | 9.0 | · | 13.9 | 7.5 | 10.9 | · | 5.4 | |
| Quick Ratio | 11.8 | 6.6 | · | 1.2 | 1.8 | 1.9 | · | 6.3 | 10.2 | 8.5 | · | 13.4 | 7.0 | 10.1 | · | 5.2 | |
| Debt / Equity | · | -0.0 | · | 0.2 | 0.1 | · | · | · | · | · | · | · | · | · | · | 0.0 | |
| LT Debt / Equity | · | -0.0 | · | 0.2 | 0.1 | · | · | · | · | · | · | · | · | · | · | · |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | 0.3 | 0.1 | 0.1 | · | 0.0 | |
| Receivables Turnover | 0.3 | 0.9 | · | 1.3 | 1.2 | 1.7 | · | 0.6 | 1.5 | 0.7 | · | 2.4 | 39.7 | 1.2 | · | · |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.16 | $-0.64 | · | $0.09 | $0.29 | $0.11 | · | $1.31 | $1.56 | $1.84 | · | $2.22 | $1.80 | $1.97 | · | $0.57 | |
| Revenue / Share | $0.01 | $0.02 | · | $0.04 | $0.05 | $0.13 | · | $0.15 | $0.04 | $0.07 | · | $0.53 | $0.18 | $0.08 | · | $0.00 | |
| Cash Flow / Share | · | $-0.15 | · | · | · | $-0.27 | · | · | · | $-0.23 | · | · | · | $-0.17 | · | · | |
| Cash / Share | $1.07 | $0.84 | · | $0.48 | $0.54 | $0.92 | · | $1.40 | $1.59 | $1.88 | · | $1.87 | $1.91 | $1.86 | · | $0.67 | |
| EPS (TTM) | $-1.33 | $-1.31 | · | $-1.88 | $-1.92 | $-2.10 | · | $-1.07 | $-0.53 | $-0.47 | · | $1.42 | $0.95 | $0.94 | · | $-0.30 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $10M | $12M | · | $15M | $15M | $14M | · | $8M | $16M | $19M | · | $57M | $45M | $42M | · | $0 | |
| Net Income TTM | $-108M | $-107M | · | $-68M | $-58M | $-59M | · | $-27M | $-14M | $-11M | · | $29M | $19M | $19M | · | $-22M | |
| Market Cap | $340M | $325M | · | $106M | $56M | $45M | · | $34M | $40M | $50M | · | $76M | $91M | $79M | · | $42M | |
| Enterprise Value | · | $266M | · | $77M | $25M | · | · | · | · | · | · | · | · | · | · | $28M | |
| P/E | -3.1 | -3.5 | · | -0.9 | -0.5 | -0.5 | · | -1.2 | -2.9 | -4.3 | · | 2.4 | 4.6 | 4.0 | · | -6.7 | |
| P/S | 34.5 | 27.1 | · | 7.3 | 3.7 | 3.3 | · | 4.1 | 2.4 | 2.7 | · | 1.3 | 2.0 | 1.9 | · | · | |
| P/B | -26.2 | -7.1 | · | 17.8 | 3.2 | 8.8 | · | 1.0 | 1.0 | 1.1 | · | 1.5 | 2.4 | 1.9 | · | 3.5 | |
| P / Tangible Book | · | · | · | 17.8 | 3.2 | 8.8 | · | 1.0 | 1.0 | 1.1 | · | 1.5 | 2.4 | 1.9 | · | 3.5 | |
| P / Cash Flow | · | -25.5 | · | · | · | -5.0 | · | · | · | -8.8 | · | · | · | -21.5 | · | · | |
| EV / Revenue | · | 22.2 | · | 5.2 | 1.6 | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -32.4% | -28.8% | · | -113.9% | -204.3% | -214.3% | · | -81.7% | -34.6% | -23.4% | · | 42.4% | 21.9% | 25.1% | · | -14.9% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $14M | $11M | $19M | $40M | $589.0K |
| Faaliyet Kâr Marjı % | -271.9% | -564.7% | -55.5% | 45.7% | -3854.8% |
| Net Gelir | $-50M | $-58M | $-10M | $18M | $-57M |
| Seyreltilmiş Hisse Başı Kâr | $-0.80 | $-2.15 | $-0.46 | $0.87 | $-3.82 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.1 | · | · | 0.0 | 0.0 |
| Cari Oran | 6.4 | 3.2 | 13.3 | 17.8 | 6.8 |
| Cari Oran | 6.1 | 3.0 | 12.7 | 16.0 | 0.1 |
Bu beyan için veri yok
Bu beyanı oluşturmak için henüz yeterli temel verisi yok.
Kurumsal Sahipler (13F) 105 dosya · $240.8M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
105
Tutulan Değer
$240.8M
Yeni pozisyonlar
39
Çıkan pozisyonlar
14
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 39 (+12 önceki Ç'ye göre) | 14 (+8 önceki Ç'ye göre) | 34 (+17 önceki Ç'ye göre) | 13 (-2 önceki Ç'ye göre) | +13.4M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Caligan Partners LP | $24.976.815 | 6.077.084 | 10,37% | Hisse senetleri |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $24.782.375 | 6.029.775 | 10,29% | Hisse senetleri |
| BIOS Capital Management, LP | $15.138.893 | 3.683.429 | 6,29% | Hisse senetleri |
| BlackRock, Inc. | $12.808.762 | 3.116.487 | 5,32% | Hisse senetleri |
| Balyasny Asset Management L.P. | $12.691.129 | 3.087.866 | 5,27% | Hisse senetleri |
| Nantahala Capital Management, LLC | $12.582.185 | 3.061.359 | 5,22% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $12.160.187 | 2.958.683 | 5,05% | Hisse senetleri |
| Boxer Capital Management, LLC | $11.569.650 | 2.815.000 | 4,80% | Hisse senetleri |
| Trails Edge Capital Partners, LP | $11.276.434 | 2.743.658 | 4,68% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $9.461.635 | 2.302.101 | 3,93% | Hisse senetleri |
| GREAT POINT PARTNERS LLC | $8.097.469 | 1.970.187 | 3,36% | Hisse senetleri |
| MARSHALL WACE, LLP | $7.996.453 | 1.945.609 | 3,32% | Hisse senetleri |
| ADAR1 Capital Management, LLC | $7.331.340 | 1.783.781 | 3,04% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $6.276.912 | 1.527.229 | 2,61% | Hisse senetleri |
| Woodline Partners LP | $5.896.670 | 1.434.713 | 2,45% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $5.622.928 | 1.367.712 | 2,33% | Hisse senetleri |
| BOOTHBAY FUND MANAGEMENT, LLC | $4.888.907 | 1.189.515 | 2,03% | Hisse senetleri |
| VANGUARD GROUP INC | $4.669.022 | 2.322.897 | 1,94% | Hisse senetleri |
| Opaleye Management Inc. | $4.623.750 | 1.125.000 | 1,92% | Hisse senetleri |
| SummitTX Capital, L.P. | $4.140.213 | 1.007.351 | 1,72% | Hisse senetleri |
| STATE STREET CORP | $3.247.459 | 790.136 | 1,35% | Hisse senetleri |
| Bleichroeder LP | $3.028.421 | 736.842 | 1,26% | Hisse senetleri |
| UBS Group AG | $2.810.808 | 683.895 | 1,17% | Hisse senetleri |
| CITADEL ADVISORS LLC | $2.735.871 | 665.662 | 1,14% | Hisse senetleri |
| MORGAN STANLEY | $1.910.739 | 464.900 | 0,79% | Hisse senetleri |
| NORTHERN TRUST CORP | $1.817.253 | 442.154 | 0,75% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $1.686.641 | 410.375 | 0,70% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.528.715 | 371.950 | 0,63% | Hisse senetleri |
| Squarepoint Ops LLC | $1.359.518 | 330.783 | 0,56% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $1.043.784 | 253.962 | 0,43% | Hisse senetleri |
| AWM Investment Company, Inc. | $955.945 | 232.590 | 0,40% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $809.247 | 196.897 | 0,34% | Hisse senetleri |
| JANE STREET GROUP, LLC | $776.741 | 188.988 | 0,32% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $678.368 | 165.053 | 0,28% | Hisse senetleri |
| Mink Brook Asset Management LLC | $662.553 | 161.205 | 0,28% | Hisse senetleri |
| XTX Topco Ltd | $592.230 | 144.095 | 0,25% | Hisse senetleri |
| Seven Fleet Capital Management LP | $588.293 | 143.137 | 0,24% | Hisse senetleri |
| Creative Planning | $527.584 | 128.366 | 0,22% | Hisse senetleri |
| Texas Capital Bank Wealth Management Services Inc | $503.594 | 122.529 | 0,21% | Hisse senetleri |
| Bank of New York Mellon Corp | $503.390 | 122.479 | 0,21% | Hisse senetleri |
| Stonepine Capital Management, LLC | $413.951 | 100.718 | 0,17% | Hisse senetleri |
| Jump Financial, LLC | $389.711 | 94.820 | 0,16% | Hisse senetleri |
| Nuveen, LLC | $293.220 | 71.343 | 0,12% | Hisse senetleri |
| Palogic Value Management, L.P. | $267.512 | 65.088 | 0,11% | Hisse senetleri |
| Aureus Asset Management, LLC | $239.202 | 58.200 | 0,10% | Hisse senetleri |
| Regency Capital Management Inc.\DE | $238.380 | 58.000 | 0,10% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $226.070 | 55.005 | 0,09% | Hisse senetleri |
| DEUTSCHE BANK AG\ | $219.113 | 53.312 | 0,09% | Hisse senetleri |
| Invesco Ltd. | $218.779 | 53.231 | 0,09% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $216.321 | 52.633 | 0,09% | Hisse senetleri |
Aktivistler ve %5+ sahipler 17 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Foundation Fighting Blindness Retinal Degeneration Fund, Foundation Fighting Blindness, Inc. ×4 başvurular | 20 Mayıs 2026 | 4,66% | Değişiklik | · | SEC |
| Dr. Chang H. Ahn Not Applicable ×3 başvurular | 09 Ekim 2013 | · | İlk başvuru | · | SEC |
| Dr. Chang H Ahn Not Applicable ×2 başvurular | 20 Mayıs 2011 | · | İlk başvuru | · | SEC |
| Rexgene Biotech Co., Ltd. Not Applicable ×3 başvurular | 30 Eylül 2009 | · | İlk başvuru | Pasif yatırım | SEC |
| KT&G Corporation Not Applicable ×2 başvurular | 26 Aralık 2007 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi | 23 Mayıs 2005 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi | 23 Mayıs 2005 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi | 23 Mayıs 2005 | · | İlk başvuru | M&A / satış | SEC |
| Açıklanmayan raporlama kişisi | 23 Mayıs 2005 | · | İlk başvuru | M&A / satış | SEC |
| Açıklanmayan raporlama kişisi | 23 Mayıs 2005 | · | İlk başvuru | M&A / satış | SEC |
| Açıklanmayan raporlama kişisi | 23 Mayıs 2005 | · | İlk başvuru | M&A / satış | SEC |
| Açıklanmayan raporlama kişisi | 23 Mayıs 2005 | · | İlk başvuru | M&A / satış | SEC |
| Açıklanmayan raporlama kişisi | 23 Mayıs 2005 | · | İlk başvuru | M&A / satış | SEC |
| Açıklanmayan raporlama kişisi | 23 Mayıs 2005 | · | İlk başvuru | M&A / satış | SEC |
| Açıklanmayan raporlama kişisi | 21 Ocak 2005 | · | İlk başvuru | M&A / satış | SEC |
| Açıklanmayan raporlama kişisi | 21 Ocak 2005 | · | İlk başvuru | M&A / satış | SEC |
| S.S or | 18 Ağustos 2004 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 45 içeriden öğrenenler · 17 yöneticiler · 31 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| George Magrath | Chief Executive Officer | 09 Eylül 2026 M | 2.048.485 | 0 | 3 | $-204.920 |
| Sooch Mina | President and CEO | 10 Ocak 2023 A | 430.501 | 0 | 0 | $0 |
| Douglas J Swirsky | President and CEO | 29 Ocak 2019 P | 50.000 | 0 | 0 | $0 |
| Peter David Suzdak | Chief Executive Officer | 28 Şubat 2018 M | 22.250 | 0 | 0 | $0 |
| Robert E. Gagnon | Chief Financial Officer | 03 Eylül 2026 S | 556.375 | 0 | 3 | $-190.702 |
| Nirav S. Jhaveri | Chief Financial Officer | 13 Mart 2025 A | 194.293 | 0 | 0 | $0 |
| Tae Heum Jeong | Chief Financial Officer | 20 Ocak 2017 A | 505.000 | 0 | 0 | $0 |
| Benjamin R Yerxa | President | 23 Temmuz 2026 S | 704.106 | 0 | 2 | $-61.207 |
| Rakesh Soni | President and COO | 12 Ocak 2014 A | · | 0 | 0 | $0 |
| Joseph K Schachle | Chief Operating Officer | 23 Temmuz 2026 S | 291.440 | 0 | 3 | $-57.696 |
| Ashwath Jayagopal | Chief Scientific & Dev. Ofc. | 23 Nisan 2026 S | 509.233 | 0 | 2 | $-58.184 |
| Rabourn Amy Zaremba | Head of Fin. Quality Assurance | 23 Nisan 2026 S | 188.671 | 0 | 2 | $-23.289 |
| Bernhard Hoffmann | SVP of Corp. Dev. | 13 Mart 2025 A | 185.446 | 0 | 0 | $0 |
| Ronil A. Patel | Chief Business Officer | 10 Ocak 2024 F | 90.714 | 0 | 0 | $0 |
| Lisa Nolan | Chief Business Officer | 28 Şubat 2019 M | 23.250 | 0 | 0 | $0 |
| Ely Benaim | Chief Medical Officer | 28 Şubat 2019 M | 4.750 | 0 | 0 | $0 |
| George F Steinfels | Chief Business Officer Sr. VP | 08 Aralık 2005 A | · | 0 | 0 | $0 |
| Cam Gallagher | Yönetim kurulu üyesi | 08 Eylül 2026 M | 2.800.111 | 2 | 0 | $323.890 |
| Jean Bennett | Yönetim kurulu üyesi | 20 Nisan 2026 A | 259.019 | 0 | 0 | $0 |
| Sean Ainsworth | Yönetim kurulu üyesi | 20 Nisan 2026 A | 321.692 | 0 | 0 | $0 |
| Susan Benton | Yönetim kurulu üyesi | 20 Nisan 2026 A | 243.894 | 0 | 0 | $0 |
| Adrienne L Graves | Yönetim kurulu üyesi | 20 Nisan 2026 A | 127.514 | 0 | 0 | $0 |
| Richard J Rodgers | Yönetim kurulu üyesi | 20 Nisan 2026 A | 343.022 | 0 | 0 | $0 |
| James S J Manuso | Yönetim kurulu üyesi | 20 Nisan 2026 A | 317.318 | 0 | 0 | $0 |
| Jay Pepose | Yönetim kurulu üyesi | 11 Haziran 2024 A | 180.458 | 0 | 0 | $0 |
| Lara Sullivan, M.D. | Yönetim kurulu üyesi | 06 Haziran 2019 A | · | 0 | 0 | $0 |
| Peter C. Brandt | Yönetim kurulu üyesi | 06 Haziran 2019 A | 150.000 | 0 | 0 | $0 |
| Ben Gil Price | Yönetim kurulu üyesi | 06 Haziran 2019 A | 15.000 | 0 | 0 | $0 |
| Charles Beever | Yönetim kurulu üyesi | 06 Haziran 2019 A | 11.000 | 0 | 0 | $0 |
| Kwang Soo Cheong | Yönetim kurulu üyesi | 06 Haziran 2019 A | 3.000 | 0 | 0 | $0 |
| Mark Carthy | Yönetim kurulu üyesi | 11 Nisan 2017 A | · | 0 | 0 | $0 |
| Chang Ho Ahn | Yönetim kurulu üyesi | 10 Nisan 2017 M | 6.010.000 | 0 | 0 | $0 |
| Si Moon Hwang | Yönetim kurulu üyesi | 09 Haziran 2014 A | · | 0 | 0 | $0 |
| David M Mcintosh | Yönetim kurulu üyesi | 09 Haziran 2014 A | 25.990 | 0 | 0 | $0 |
| Richard Kivel | Yönetim kurulu üyesi | 18 Haziran 2012 A | 2.500 | 0 | 0 | $0 |
| Freddie Ann Hoffman | Yönetim kurulu üyesi | 01 Haziran 2009 A | 1.000 | 0 | 0 | $0 |
| Michele Y Kang | Yönetim kurulu üyesi | 01 Haziran 2009 A | 10.000 | 0 | 0 | $0 |
| Young Soon Park | Yönetim kurulu üyesi | 11 Aralık 2006 G | 2.040.500 | 0 | 0 | $0 |
| John W Holaday DR | Yönetim kurulu üyesi | 02 Mayıs 2006 A | · | 0 | 0 | $0 |
| Inok Ahn | Yönetim kurulu üyesi | 08 Aralık 2005 A | · | 0 | 0 | $0 |
| Jang Han Rhee | Yönetim kurulu üyesi | 13 Mayıs 2005 A | 2.000.000 | 0 | 0 | $0 |
| Suk Hyung Kwon | Yönetim kurulu üyesi | 13 Mayıs 2005 A | 114.255 | 0 | 0 | $0 |
| Frank Ferraro | Yönetim kurulu üyesi | 11 Ocak 2005 S | 0 | 0 | 0 | $0 |
| Rexgene Biotech Co., Ltd. | 10% sahip | 24 Aralık 2007 A | 5.505.956 | 0 | 0 | $0 |
| Alan R Meyer | · | 19 Kasım 2020 P | 487.029 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 10 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,69% | 33.112 SH | 01 Ekim 2026 | Günlük |
| IWC · iShares Trust | 0,08% | 182.492 SH | 11 Eylül 2026 | Günlük |
| IWO · iShares Trust | 0,02% | 502.884 SH | 11 Eylül 2026 | Günlük |
| IWM · iShares Trust | 0,01% | 1.380.383 SH | 11 Eylül 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 309.583 SH | 19 Ağustos 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 57.702 SH | 19 Ağustos 2026 | Günlük |
| RSSL · Global X Funds | 0,01% | 25.597 NS | 31 Temmuz 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 652.278 SH | 19 Ağustos 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.239.388 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4.665 SH | 19 Ağustos 2026 | Günlük |
IRD Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 23 analist
AL
Medyan hedef
$12.00
+162,0%
6 26,1%
Güçlü Al
16 69,6%
Al
1 4,3%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
17 analist · 2026-10-03Ortalama hedef $13.00 +183,8%
← Tüm hedeflerin altında
Mevcut fiyat $4.58
Düşük$8.00
Ortalama$13.00
Yüksek$20.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| IRD | $140M | -2.5 | 29.1% | -349.3% | -302.2% | · |
| KYTX | $568M | -2.6 | · | · | -77.4% | · |
| EIKN | · | · | · | · | · | · |
| XFOR | $364M | -2.1 | 150.0% | -1218.5% | -83.2% | · |
| AGEN | $111M | · | 10.4% | -2.7% | 1.0% | · |
| ENTA | $256M | -3.1 | -3.4% | -125.4% | -103.5% | · |
| ARCT | $174M | -2.6 | -46.1% | -80.2% | -29.6% | · |
| INDP | $6M | -0.1 | · | · | -2820.8% | · |
| FENC | $263M | -22.6 | -6.1% | -21.8% | -69.6% | · |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 6, 2026